+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urinary System Antibiotics Market - Global Forecast 2025-2030- Product Image
Urinary System Antibiotics Market - Global Forecast 2025-2030- Product Image
Sale

Urinary System Antibiotics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6131496
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The urinary system antibiotics market is experiencing pivotal change fuelled by advancements in therapeutics, regulatory shifts, and global supply chain dynamics. Senior leaders must navigate a complex environment shaped by technology innovation, evolving stewardship priorities, and rising cost pressures to ensure sustainable growth and patient safety.

Market Snapshot

The urinary system antibiotics sector is marked by a broadening product landscape and rapid incorporation of targeted therapies. Emerging technologies, coupled with an increased focus on patient-centric care, are driving new delivery models. Demand continues to rise as healthcare providers face higher infection rates, propelled by demographic shifts and increased device use in medical settings. As healthcare systems adopt value-based and digital-first strategies, decision-makers face mounting pressure to align new therapeutic approaches with streamlined operations and regulatory compliance, while maintaining clinical efficacy.

Scope & Segmentation

  • Route of Administration: Intravenous, Oral
  • Indication: Prophylaxis, Acute Uncomplicated UTI, Complicated UTI (including Cystitis, Pyelonephritis)
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Dosage Form: Capsule, Injection, Oral Suspension, Tablet
  • Drug Class: Beta-Lactams (Carbapenems, Cephalosporins – First through Fourth Generation, Penicillins), Fluoroquinolones, Nitrofurans, Phosphonic Acid Derivatives, Sulfonamides
  • Geographic Regions: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Covered Companies: Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Bayer AG, Novartis AG, Merck & Co., Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Sandoz AG, Viatris Inc.

Key Takeaways

  • A shift toward targeted, microbiome-friendly urinary system antibiotics is altering development priorities, promoting patient safety and reducing recurrent infections.
  • Innovative drug delivery methods such as extended-release and targeted prodrugs are improving tissue targeting and minimizing system-wide exposure, aiding treatment effectiveness and adherence.
  • Digital health solutions, including digital adherence tools and telemedicine platforms, are enabling real-time monitoring and more responsive patient care, supporting stewardship principles in diverse care settings.
  • The expanding regional focus, especially in Asia-Pacific and emerging EMEA markets, underscores the need for local manufacturing innovation, customized regulatory strategies, and diversified supply chains for reliable access.
  • Integration of diagnostics and companion tools into the therapeutic workflow is supporting precision medicine efforts, facilitating tailored antibiotic selection, and enhancing treatment outcomes.
  • Competitive strategies among leading pharmaceutical companies hinge on real-world evidence, strategic partnerships, and adaptive trial designs to respond to a rapidly evolving global resistance landscape.

Tariff Impact on Supply Chains

The 2025 United States tariff adjustments have imposed additional costs on key active pharmaceutical ingredients and excipients, prompting manufacturers to reexamine procurement strategies and accelerate local sourcing initiatives. These changes are driving increased investment in domestic production capabilities and triggering a rebalancing of regional supply chains. Regulatory bodies have responded by expediting approvals for import substitutions, demanding strict adherence to quality standards and frequent engagement between industry and regulators. The cumulative effect is a more intricate supply network requiring ongoing vigilance from senior decision-makers.

Methodology & Data Sources

This report employs a rigorous methodology combining primary interviews with infectious disease experts, pharmacists, and procurement leaders, supported by robust secondary research across clinical trials, regulatory data, and company disclosures. Systematic triangulation and sensitivity analysis enhance data reliability and ensure recommendations reflect both current insights and potential market shifts.

Why This Report Matters

  • Enables leaders to align R&D investment and regulatory actions with evolving market challenges and opportunities in the urinary system antibiotics market.
  • Provides strategic insights to optimize pricing, distribution, and portfolio management amid new supply chain realities and digital health integration.
  • Delivers a consolidated, actionable perspective for risk assessment, partner selection, and long-term operational planning.

Conclusion

Stakeholders in the urinary system antibiotics segment must balance innovation, compliance, and patient care while navigating regional and technological complexity. This report offers the strategic intelligence necessary for forward-looking decision-making and resilient market positioning.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising prevalence of antibiotic-resistant urinary tract infections driving novel therapeutic development
5.2. Adoption of narrow-spectrum antibiotics to reduce gut microbiome disruption in UTI treatment
5.3. Integration of rapid molecular diagnostics in clinical workflows to optimize antibiotic selection for UTIs
5.4. Growth of outpatient parenteral antibiotic therapy programs reducing hospital stays for complex UTIs
5.5. Increased investment in alternative antibacterial modalities such as bacteriophage therapy for UTIs
5.6. Impact of telehealth expansion on antibiotic stewardship and prescription patterns in UTI management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Urinary System Antibiotics Market, by Route Of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
9. Urinary System Antibiotics Market, by Indication
9.1. Introduction
9.2. Prophylaxis
9.3. Treatment
9.3.1. Acute Uncomplicated Uti
9.3.2. Complicated Uti
9.3.2.1. Cystitis
9.3.2.2. Pyelonephritis
10. Urinary System Antibiotics Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Urinary System Antibiotics Market, by Dosage Form
11.1. Introduction
11.2. Capsule
11.3. Injection
11.4. Oral Suspension
11.5. Tablet
12. Urinary System Antibiotics Market, by Drug Class
12.1. Introduction
12.2. Beta-Lactams
12.2.1. Carbapenems
12.2.2. Cephalosporins
12.2.2.1. First Generation
12.2.2.2. Fourth Generation
12.2.2.3. Second Generation
12.2.2.4. Third Generation
12.2.3. Penicillins
12.3. Fluoroquinolones
12.4. Nitrofurans
12.5. Phosphonic Acid Derivatives
12.6. Sulfonamides
13. Americas Urinary System Antibiotics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Urinary System Antibiotics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Urinary System Antibiotics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. GlaxoSmithKline plc
16.3.3. Johnson & Johnson
16.3.4. Bayer AG
16.3.5. Novartis AG
16.3.6. Merck & Co., Inc.
16.3.7. Sanofi S.A.
16.3.8. Teva Pharmaceutical Industries Ltd.
16.3.9. Sandoz AG
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. URINARY SYSTEM ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. URINARY SYSTEM ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. URINARY SYSTEM ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. URINARY SYSTEM ANTIBIOTICS MARKET: RESEARCHAI
FIGURE 26. URINARY SYSTEM ANTIBIOTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. URINARY SYSTEM ANTIBIOTICS MARKET: RESEARCHCONTACTS
FIGURE 28. URINARY SYSTEM ANTIBIOTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. URINARY SYSTEM ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ACUTE UNCOMPLICATED UTI, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ACUTE UNCOMPLICATED UTI, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CYSTITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CARBAPENEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CARBAPENEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY FOURTH GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY FOURTH GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY NITROFURANS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY NITROFURANS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY PHOSPHONIC ACID DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY PHOSPHONIC ACID DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 126. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 127. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 128. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 129. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 132. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 133. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 134. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 135. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 136. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 137. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 138. CANADA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 144. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 145. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 146. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 147. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 150. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 151. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 231. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 236. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 237. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 238. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 239. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 245. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 246. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 247. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 248. GERMANY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 249. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 254. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 255. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 256. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 257. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 262. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 263. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 264. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 265. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 266. FRANCE URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 285. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 290. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 291. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 292. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 293. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 296. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 297. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 298. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 299. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2018-2024 (USD MILLION)
TABLE 300. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY BETA-LACTAMS, 2025-2030 (USD MILLION)
TABLE 301. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2024 (USD MILLION)
TABLE 302. ITALY URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2025-2030 (USD MILLION)
TABLE 303. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 308. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 309. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2018-2024 (USD MILLION)
TABLE 310. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY COMPLICATED UTI, 2025-2030 (USD MILLION)
TABLE 311. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 314. SPAIN URINARY SYSTEM ANTIBIOTICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 315. SPAIN URINARY SYSTEM

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Urinary System Antibiotics market report include:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Bayer AG
  • Novartis AG
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz AG
  • Viatris Inc.

Related Topics

Related Reports

Antibacterial Drugs - Global Strategic Business Report - Product Image

Antibacterial Drugs - Global Strategic Business Report

  • Report
  • 244 Pages
  • Global
From
EU - Antibiotics - Market Analysis, Forecast, Size, Trends and Insights - Product Image

EU - Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • Europe
From
Antibiotic Impregnated Joint Spacer Market - Global Forecast 2025-2030 - Product Image

Antibiotic Impregnated Joint Spacer Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Beta-Lactam and Beta-Lactamase Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Beta-Lactam and Beta-Lactamase Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Beta Lactam & Beta Lactamase Inhibitors Market - Global Forecast 2025-2030 - Product Image

Beta Lactam & Beta Lactamase Inhibitors Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.